Melody.education: Educational programs on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD)

Prof Michael Trauner presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Welcome and Introduction

May 9, 2024
Explore the alarming rise of Nonalcoholic Steatohepatitis (NASH) and its connection to global health issues like obesity and diabetes. Delve into the significance of liver fibrosis and its role in the disease’s progression. The emerging role of the hepatic thyroid hormone pathway in understanding NASH's pathology is also highlighted. This discussion sheds light on therapeutic needs and potential advancements in managing this prevalent condition.
Ask episode
Chapters
Transcript
Episode notes